When disasters occur, organizations such as SCAN Health Plan take a holistic approach, considering the needs of members, providers, brokers, employees and the broader community.
In the wake of natural disasters, organizations such as SCAN Health Plan play a crucial role in supporting community resilience.
Karen Schulte, president of SCAN Health Plan, recently shared insights on how the organization responds to crises, particularly in disaster-prone regions like Southern California—where most of their coverage area lies.
SCAN’s services also reach those who live in other disaster-prone states, including Arizona, Nevada, New Mexico and Texas.
Schulte expressed that when disasters occur, SCAN takes a holistic approach, considering the needs of members, providers, brokers, employees and the broader community.
“This is one of the things, as you can imagine, when it first hit, there was just a high degree of freneticism, or like, what do we do? What's exactly happening?” she said, referring to the wildfires that wiped out over 37,000 acres of land across Southern California in January after burning for 24 days.
To address this, SCAN set up a command center through their business continuity team, which brought together leadership to coordinate support efforts such as reaching out by phone or going door-to-door to members’ homes.
One immediate priority was assisting those in their institutional special needs plans, particularly those in assisted living communities.
For instance, due to the fires, two communities burned, and 15 others had to be evacuated, she said.
SCAN quickly deployed clinical teams to assist displaced residents and coordinate with local agencies to ensure continued care and access to necessary supplies.
Beyond physical health needs, SCAN also focuses on mental health support during and after disasters.
Schulte highlighted that recognizing and taking care of the needs of first responders is crucial in order to effectively help others.
With that, the organization prioritizes employee well-being while also connecting affected individuals with community resources.
SCAN works to provide information and assistance to those facing uncertainty, such as where to find temporary housing or how to navigate financial challenges after losing a home.
Collaboration with local and state agencies is also a key element of SCAN's disaster response.
Schulte noted that strong partnerships enable an organization to assist in evacuations, provide bedside care and distribute supplies to both members and others affected.
“This is certainly one of those instances where it takes a village, right?” she asked. “And we're very grateful for the strong relationships we have with both local and state agencies."
By prioritizing rapid response, mental health support and collaboration with government and community organizations, SCAN Health Plan demonstrates its commitment to resilience and care in times of crisis.
FDA Approves Amvuttra for ATTR-CM in Extended Label
March 21st 2025This expanded indication for Amvuttra makes it the first and only FDA-approved treatment for transthyretin amyloidosis with cardiomyopathy (ATTR-CM) and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
FDA Approves First-Ever Cell Therapy Treatment for Rare Progressive Eye Disease
March 20th 2025Encelto is small, semi-permeable capsule implanted in the eye that contains allogeneic retinal pigment epithelium cells genetically engineered to produce specific therapeutic proteins. It will be available in June 2025.
Read More